ABSTRACT DNA damage tolerance and homologous recombination pathways function to bypass replication-blocking lesions and ensure completion of DNA replication. However, inappropriate activation of these pathways may lead to increased mutagenesis or formation of deleterious recombination intermediates, often leading to cell death or cancer formation in higher organisms. Posttranslational modifications of PCNA regulate the choice of repair pathways at replication forks. Its monoubiquitination favors translesion synthesis, while polyubiquitination stimulates template switching. Srs2 helicase binds to small ubiquitin-related modifier (SUMO)-modified PCNA to suppress a subset of Rad51-dependent homologous recombination. Conversely, SUMOylation of Srs2 attenuates its interaction with PCNA. Sgs1 helicase and Mus81 endonuclease are crucial for disentanglement of repair intermediates at the replication fork. Deletion of both genes is lethal and can be rescued by inactivation of Rad51-dependent homologous recombination. Here we show that Saccharomyces cerevisiae Uls1, a member of the Swi2/Snf2 family of ATPases and a SUMOtargeted ubiquitin ligase, physically interacts with both PCNA and Srs2, and promotes Srs2 binding to PCNA by downregulating Srs2-SUMO levels at replication forks. We also identify deletion of ULS1 as a suppressor of mus81D sgs1D synthetic lethality and hypothesize that uls1D mutation results in a partial inactivation of the homologous recombination pathway, detrimental in cells devoid of both Sgs1 and Mus81. We thus propose that Uls1 contributes to the pathway where intermediates generated at replication forks are dismantled by Srs2 bound to SUMO-PCNA. Upon ULS1 deletion, accumulating Srs2-SUMO-unable to bind PCNA-takes part in an alternative PCNA-independent recombination repair salvage pathway(s).
2008; Vanoli et al. 2010; Minca and Kowalski 2011) . This demonstrates the importance of both DDT-and HR-mediated pathways in coping with various forms of replication stress, although their relative contributions and interactions have not been well established (Unk et al. 2010; Sale 2012; Symington et al. 2014) .
DDT pathways are regulated by post-translational modifications of proliferating cell nuclear antigen (PCNA) which forms a homotrimeric ring around DNA and serves as a binding platform for DNA polymerases and other replicationassociated proteins (Moldovan et al. 2007 ) ( Figure S1 in File S1). Formation of single-strand DNA (ssDNA) gaps coated by replication protein A at the stalled replication fork recruits the Rad6-Rad18 E2-E3 ubiquitin ligase complex that promotes monoubiquitination of PCNA at highly conserved Lys164 (Hoege et al. 2002; Davies et al. 2008) . This modification creates a binding site for TLS polymerases (Bienko et al. 2005) . The error-free mode of DDT is activated when the monoubiquitinated PCNA is further polyubiquitinated by the E2 heterodimer Ubc13-Mms2 and the E3 ubiquitin ligase Rad5 (Hofmann and Pickart 1999; Ulrich and Jentsch 2000; Hoege et al. 2002) . Additionally, during unperturbed replication, the small ubiquitin-related modifier (SUMO) (Smt3 in yeast) is attached to PCNA predominantly at Lys164 by SUMO ligase Siz1, and also at Lys127 by Siz1 and Siz2 (Hoege et al. 2002; Parker et al. 2008) . It was reported that PCNA SUMOylation mediates the recruitment of the Srs2 helicase to the replication fork, leading to prevention of a subset of HR repair. This HR inhibition by Srs2 is toxic in rad18 and rad5 mutants (Papouli et al. 2005; Pfander et al. 2005) , confirming the role of both HR and DDT in the replication stress response. On the other hand, Srs2-PCNA interaction was also demonstrated to limit the length of DNA repair synthesis and thus favor the HR synthesis-dependent strand annealing pathway (SDSA) (Burkovics et al. 2013; Miura et al. 2013) . Importantly, Srs2 was also shown to have the ability to dismantle Rad51 nucleofilaments and to inhibit Rad51-driven DNA strand exchange (Krejci et al. 2003; Veaute et al. 2003) . The Srs2 helicase itself can undergo SUMOylation, which disfavors its binding to SUMO-PCNA but is important for its interaction with Rad51 and other recombination factors (Kolesar et al. 2012 (Kolesar et al. , 2016 . Therefore, modulation of the equilibrium between unmodified and modified forms of Srs2 plays a role in the choice of pathway used to deal with replication stress.
Perturbations in replication fork progression can lead to fork collapse and double-strand break (DSB) formation. Srs2 promotes their repair by SDSA, yielding noncrossing over (non-CO) products and thus limiting loss of heterozygosity events in mitotic cells (Ira et al. 2003; Niu and Klein 2016) . Nonetheless, D-loops formed after Rad51 recombinasedependent strand invasion might be stabilized and extended until a second end of a DNA break is captured. Most resulting joint molecules are single or double Holliday junctions (HJs). Double HJs are dissolved by the complex consisting of the Sgs1 helicase, the DNA topoisomerase Top3, and the stimulatory protein Rmi1 (Gangloff et al. 1994; Mullen et al. 2005; Cejka et al. 2010) resulting in non-CO recombination products. Recombination intermediates that escaped dissolution by the Sgs1-Top3-Rmi1 complex in S phase or were converted into single HJs are resolved by the Mus81-Mms4 endonuclease in G 2 /M leading exclusively to CO products (Matos et al. 2013; Szakal and Branzei 2013) . Any remaining joint molecules are removed by the Yen1 endonuclease during anaphase to complete the repair and disconnect the sister chromatids before chromosome segregation in mitosis (Blanco et al. 2014) , yielding both CO and non-CO products ( Figure S1 in File S1). Single HJ can also be processed by Srs2 (Mitchel et al. 2013) , demonstrating that Srs2 and Sgs1 can jointly regulate non-CO formation either by promoting the SDSA pathway or by processing HJ-type intermediates. The significance of these alternative pathways preventing the accumulation of toxic recombination intermediates, which arise during replication stress, is manifested by synthetic lethality of sgs1D srs2D and mus81D sgs1D double mutations that can be rescued by deletion of RAD51 (Mullen et al. 2001; Fabre et al. 2002) .
ULS1 (DIS1/RIS1), due to the presence of the C-terminal Swi2/Snf2-related DNA translocase domain, was implied to play a role in DNA repair and chromatin remodeling. Uls1 also possesses four SUMO-interacting motifs (SIMs) in its N-terminal part and a C-terminal RING domain, a signature structure for ubiquitin ligases. Uls1 interacts with SUMO and Ubc4, the E2 ubiquitin-conjugating enzyme, while uls1D cells accumulate high-molecular-weight SUMO conjugates, which led to its classification as a SUMO-targeted ubiquitin ligase (STUbL) (Uzunova et al. 2007 ). Additionally, Uls1 was proposed to function in nonhomologous end joining inhibition by dislodging poly-SUMOylated Rap1 molecules from telomeres (Lescasse et al. 2013) . However, enzymatic activity of Uls1 has never been biochemically demonstrated and little is known about its targets.
We have shown that Uls1 is involved in the replication stress response and its presence is detrimental in the sgs1D mutant (Cal-Bąkowska et al. 2011; Kramarz et al. 2014) . Importantly, roles of Uls1 in DNA metabolism require an ATP-dependent translocase activity, RING domain, and SIMs (Cal-Bąkowska et al. 2011; Chi et al. 2011; Lescasse et al. 2013; Tan et al. 2013; Kramarz et al. 2014) . It can therefore be hypothesized that Uls1 may regulate DNA-repair-pathway choice at the sites of replication-associated DNA damage by modifying SUMOylation status and thus the abundance and/or activities of its target proteins.
Here we identify deletion of ULS1 as a suppressor of mus81D sgs1D synthetic lethality and suggest that Uls1 assists in a Rad51-dependent pathway detrimental in this mutant. We also demonstrate that Uls1 downregulates the level of Srs2 SUMOylation, favoring Srs2 interaction with PCNA, and thus promoting the PCNA-Srs2-dependent DNA damage tolerance pathway. We propose that this activity might contribute to Uls1 toxicity in mutants devoid of the Sgs1 helicase.
Materials and Methods

Yeast strains, plasmids, and growth conditions
Strains and plasmids used in this study are listed in Tables S1 and  S2 in File S1, respectively. Gene deletion or tagging was performed using either a PCR-based replacement method or by genetic crossing of relevant mutants followed by tetrad dissection. Doubling time measurements were performed as previously described (Bernstein et al. 2009 ). To assess the sensitivity of selected mutants to hydroxyurea (HU) or methyl methanesulfonate (MMS), midlog-phase cells were serially diluted and spotted onto solid media containing various concentrations of DNA-damaging agents. Plates were photographed after 3 days of incubation at 30°. To synchronize cells in G 1 , midlog cultures were incubated for 2 hr in the presence 5 mM a-factor. Subsequently, pheromone was removed by extensive washing with water and cells were released into medium containing the appropriate genotoxic agent.
Viability counts
To determine the effect of GALS-HA-ULS1 expression in the mus81D sgs1D background on cell viability, the triple mutant was cultured in YPD medium to an OD 600 of 0.8. After extensive washing, one half of the culture was transferred to fresh YPD and the second half was resuspended in YPGal medium. After 4 hr incubation, cultures were diluted to an OD 600 of 0.8 in the same medium. At the indicated time points, samples were washed, diluted, and plated onto YPD medium to determine the number of viable cells able to form colonies. The numbers of viable cells were normalized by their values at time zero.
Yeast two-hybrid assay
Gal4-based Matchmaker Two-Hybrid System 3 (Clontech) was used to study the protein interactions according to manufacturer's instructions. The two-hybrid constructs used in this study were described in Parker and Ulrich (2012) , Tan et al. (2013) , and Kolesar et al. (2016) ; except for the following truncated versions of ULS1 designed for this work: pGADT7-Uls1_N (2-878), pGADT7-Uls1_C (879-1619), pGBKT7-Uls1_N (2-878), and pGBKT7-Uls1_C (879-1619).
Analysis of whole-protein extracts
Protein extracts were prepared by the trichloroacetic acid (TCA) method. Briefly, logarithmic cells of indicated strains were harvested and lysed with lysis buffer (2 M NaOH, 7% b-mercaptoethanol). Total protein was precipitated by adding 50% TCA, pellet was washed with 1 M Tris at pH 8 and resuspended in 23 Laemmli buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 2% b-mercaptoethanol). Obtained samples were analyzed by SDS-PAGE and Western blotting using anti-Srs2 (sc-11989; Santa Cruz) or anti-HA (12CA5; Roche). Blotted membranes were stained with the Ponceau S reagent (Sigma-Aldrich) to detect total proteins.
Detection of SUMOylated Srs2
Cells transformed with pWJ1509 (pCUP1-SRS2) or pAM19 (pCUP1-srs2-R1) (León Ortiz et al. 2011) were grown to midlog phase followed by 4 hr incubation in the presence of 200 mM CuSO 4 to induce SRS2 gene expression. Cell pellets were collected, washed once with 1 ml of 20% TCA, and frozen. For immunoprecipitation (IP) in denaturing conditions, cells were resuspended in 1 ml of 20% TCA and disrupted by bead beating. Precipitates were recovered by centrifugation (10 min, 13,000 rpm, 4°). Denatured proteins in pellets were resuspended in 23 Laemmli buffer and boiled for 5 min. Then, 10 ml of the resulting protein extracts was used as a loading control for the IP reaction. For each IP, 100 ml of protein extract was diluted with 400 ml of IP buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP-40) and 40 ml of anti-Srs2 (sc-11989; Santa Cruz) antibody was added. The IP reaction was allowed to continue overnight at 4°on a rotator wheel. The negative control for each IP was the diluted protein extract with IP buffer without antiSrs2 antibody. The next day, prewashed Protein G Magnetic Beads (Dynabeads; Invitrogen, Carlsbad, CA) were added for additional 2 hr at 4°. Beads were washed three times with IP buffer and bound proteins were eluted with 20 ml of 23 Laemmli buffer for 10 min at 65°. The eluted proteins were resolved on Mini-PROTEAN TGX Precast Gel 4-15% (Bio-Rad, Hercules, CA) and Western blot using anti-Srs2 (sc-11989; Santa Cruz) antibody was performed. After visualizing Srs2 protein, the membrane was stripped with 0.4 M NaOH and probed with anti-SUMO antibody Rockland) to detect the SUMOylated forms of Srs2 protein.
Quantification of Srs2 and Srs2-SUMO levels
To quantify the levels of Srs2 in analyzed strains, the signal corresponding to Srs2 and its SUMOylated forms was measured and compared with the Ponceau S signal at the respective molecular weight or immunoprecipitated Srs2 band using Image Lab (Bio-Rad). In the analysis of protein stability by cycloheximide (CHX) chase assay, the intensities of Srs2 bands vs. those of G-6-PDH bands were quantified with Image Lab (Bio-Rad). Statistical significance of observed differences was examined by t-test calculation of the P-values from independent experiments with GraphPad Software (QuickCalcs).
Analysis of protein stability
Yeast cells were synchronized in G 1 phase and released into YPD containing 0.03% MMS and 50 mg/ml CHX. Samples were collected at indicated time points and disrupted by bead beating in 20% TCA as described above. Once lysed, denatured proteins were resuspended in SDS-loading Sample Buffer (80 mM Tris-HCl, pH 8.0, 3.5% SDS, 15% glycerol, 100 mM DTT, 8 mM EDTA, 1 mM PMSF) and incubated for 20 min at 42°. Next, protein extracts were boiled for 4 min and subjected to SDS-PAGE and Western blotting with the anti-Srs2 antibody (sc-11989; Santa Cruz) and anti-G-6-PDH (A9521-1VL; Sigma-Aldrich) as a loading control.
Co-IP
Cells were grown to midlog phase, harvested, and frozen at 280°. Co-IP using the rabbit polyclonal anti-PCNA (Pol30) antibody (Zhang et al. 2000) was performed with lysis buffer L1 (50 mM Tris at pH 8.0, 100 mM NaCl, 1 mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 10% glycerol, 0.5 mM PMSF). Co-IP using anti-HA (12CA5; Roche) antibodies was performed with lysis buffer L2 (20 mM Tris-HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 1% NP-40, 2 mM EDTA). In both cases, cells were resuspended in 700 ml of precooled lysis buffer L1 or L2 supplemented with cOmplete Protease Inhibitor Cocktail (Roche) and 1 mM PMSF. Then cells were disrupted by bead beating at 4°. The appropriate antibody was added to resulting total extracts and the IP reaction was allowed to continue overnight at 4°on a rotator wheel. The negative control in each case was total extract without addition of the respective antibody. The next day, prewashed Protein G Magnetic Beads (Dynabeads; Invitrogen) were added to each reaction for an additional 2 hr. Then, beads were washed three times with an adequate lysis buffer and bound proteins were eluted with 20 ml of 23 Laemmli buffer for 10 min at 65°. The eluted proteins were resolved on Mini-PROTEAN TGX Precast Gel 4-15% (Bio-Rad) and transferred onto nitrocellulose membrane. After Ponceau S staining, the membrane was cut into fragments corresponding to the size of analyzed proteins. Each fragment was then immunoblotted with the appropriate primary antibody (anti-PCNA, anti-Srs2, or anti-HA).
Data availability
The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article. Plasmids and strains are available upon request.
Results
Uls1 presence contributes to the severe synthetic growth defect of the double mutant devoid of Mus81 endonuclease and Sgs1 helicase
We have previously shown that Uls1 has a role in dealing with perturbations in DNA replication that is independent of both Mus81 and Yen1 endonucleases, and that deletion of ULS1 attenuates the replication stress-related defects of the sgs1D mutant in a Rad51 recombinase and Rad18-, Rad5-dependent manner (Kramarz et al. 2014) .
It was thus interesting to examine the effect of ULS1 deletion on the mus81D sgs1D double mutant. We found upon sporulation of the heterozygous diploid that most spores of the sgs1D mus81D uls1D genotype were viable, although slow growing ( Figure 1A ). To confirm that the observed rescue of a sgs1D mus81D double mutant's severe synthetic growth defect was indeed due to the depletion of Uls1 protein, we constructed a heterozygous diploid containing sgs1D and mus81D as well as the HA-ULS1 gene under the control of a GALS promoter inserted in the endogenous ULS1 locus. We demonstrated that adding an HA tag does not change Uls1 activity, since the presence of HA-Uls1 rescued the increased genotoxin sensitivity of the mus81D GALS-HA-ULS1 mutant ( Figure S2 in File S1). In addition, overproduction of HA-Uls1 from either GALS or the ADH1 promoter was toxic in the sgs1D mutant ( Figure S2 in File S1) as described before for untagged Uls1 (Cal-Bąkowska et al. 2011) . We then analyzed several mus81D sgs1D GALS-HA-ULS1 clones on YP medium containing glucose or galactose as a carbon source when the expression of ULS1 gene was repressed or induced, respectively. We found that the mus81D sgs1D GALS-HA-ULS1 mutant cultured on glucose increased its cell numbers nearly eightfold during 24 hr, while shifting the cells to galactose resulted in a decrease in the viable cell numbers to about one fourth of the initial cell count ( Figure 1B ). This corresponded with the maximum of appearance of the HA-Uls1 protein after 12 hr induction, as indicated by Western blot ( Figure 1C) .
It is worth noting that phenotypes of the mus81D sgs1D GALS-HA-ULS1 and mus81D sgs1D uls1D mutants grown on media containing glucose were indistinguishable and comparable to that of the mus81D sgs1D rad51D mutant, a wellknown suppressor of the mus81D sgs1D synthetic growth defect (Fabre et al. 2002) . They all had growth defects, with generation times (180-190 min) twice as long as wild type, and were extremely sensitive to MMS and HU ( Figure 1D and data not shown).
Srs2 as a target of Uls1 activity
The srs2D sgs1D double mutant's synthetic sickness is also rescued by deletion of RAD51 (Klein 2001; Fabre et al. 2002) , but here we show that deletion of ULS1 did not lead to the rescue of the synthetic lethality of a sgs1D srs2D double mutant ( Figure S3 in File S1). This raises the possibility that the Srs2-dependent pathway might play a role in the alleviation of the replication stress-related defects in sgs1D cells by deletion of ULS1.
Srs2 protein is known to be SUMOylated in a manner largely dependent on the presence of its SIM (Kolesar et al. 2012) . Uls1, as a proposed SUMO-targeted ubiquitin ligase (Uzunova et al. 2007; Lescasse et al. 2013; Kramarz et al. 2014) , could affect this post-translational modification and thus influence Srs2 activity.
To investigate this possibility, we transformed wild type, uls1D, and a strain overexpressing ULS1 from a constitutive ADH1 promoter with plasmids harboring genes for SRS2 or srs2-R1, devoid of a SIM (Le Breton et al. 2008; León Ortiz et al. 2011) , under the control of a copper-induced CUP1 promoter. We found that in the protein extract from the uls1D strain overexpressing the SRS2 gene, Srs2 protein migrated as a more profuse band of heavier molecular weight ( Figure  2A and Figure S4A in File S1). This was not seen for the uls1D strain overexpressing the srs2-R1 allele, or for wild type overexpressing SRS2 or srs2-R1, suggesting that deletion of ULS1 might lead to the accumulation of heavy molecular, possibly SUMOylated, forms of Srs2. Moreover, in strains overexpressing ULS1, the level of both Srs2 and Srs2-R1 was reduced approximately by half (Figure 2A and Figure S4A in File S1). To confirm that the accumulating heavy molecular forms of Srs2 were indeed SUMOylated, we immunoprecipitated proteins from extracts from the transformants described above, using the anti-Srs2 antibody, and analyzed the immunoprecipitates by Western blot with anti-SUMO and anti-Srs2 antibodies. Indeed, deletion of ULS1 resulted in the accumulation of SUMOylated forms of Srs2 protein, while overproduction of Uls1 led to a decrease in the amount of Srs2-SUMO ( Figure 2B compare lane 2 with 4 and 6, and Figure S4B in File S1). The Srs2 SIM has earlier been demonstrated to be required not only for its binding to PCNA, but also for its SUMOylation under unperturbed conditions (Le Breton et al. 2008; Armstrong et al. 2012; Kolesar et al. 2012) . Consistently, we observed virtually no Srs2-SUMO conjugates in immunoprecipitates from transformants containing Srs2-R1 protein, devoid of SIM ( Figure 2B compare lane 2 with 8, 10, 12; and Figure S4B in File S1).
Srs2 has been shown to interact with Slx5, a second STUbL (Urulangodi et al. 2015 ), so we compared the level of Srs2-SUMO in slx5D and uls1D mutants overexpressing SRS2. In total protein extract preparations from slx5D and uls1D mutants, we could observe a significant increase in the signal corresponding to the Srs2 protein and its heavier, modified forms, compared to wild type ( Figure 3A) . We probed Srs2 immunoprecipitates from these strains with anti-SUMO antibody and confirmed that these species corresponded to Srs2-SUMO ( Figure 3B ). Taken together, these data demonstrate that deletion of SLX5 as well as ULS1 results in the accumulation of Srs2-SUMO conjugates.
The analysis of protein stability by CHX chase revealed that Slx5-Slx8 STUbL is involved in the regulation of endogenous Srs2 levels (Urulangodi et al. 2015) . Since we found, as shown in Figure 2A , that in strains overexpressing ULS1 the level of Srs2 is reduced, we also examined the stability of the endogenous Srs2 protein by CHX chase in wild type and uls1D and compared it to the slx5D mutant. We found that in both mutants the Srs2 protein level was stabilized, while it dropped by about half in wild type ( Figure 3C) ; confirming that Uls1 also mediates Srs2 turnover, similarly to Slx5-Slx8 (Urulangodi et al. 2015) . However, SLX5 and SLX8 have been shown to have negative interactions with ULS1 (Collins et al. 2007 ) and we also demonstrated that the uls1D slx5D mutant has a stronger growth defect and is more sensitive to HU and MMS than the single slx5D mutant (Kramarz et al. 2014) . Additionally, Tan et al. (2013) described an antagonistic relationship between ULS1 and SLX5. Moreover, while deletion of uls1D alleviates sgs1D sensitivity to MMS and HU (CalBąkowska et al. 2011) , the slx5D sgs1D double mutant is lethal (Mullen et al. 2001) . This suggests that Uls1 and Slx5 also have separate functions in the cell.
We were unable to detect a signal from Uls1 on Western blot when it was expressed from its native promoter, so to examine the Uls1-Srs2 interaction we used the srs2D strain overexpressing HA-ULS1 and either wild-type SRS2 or srs2-R1. We demonstrated by IP that Uls1 was able to bind to Srs2 even in the absence of SIM in Srs2 ( Figure 4A ). Using the yeast twohybrid system, we mapped the Srs2-Uls1 interaction site to the N-terminal fragment of Uls1 and C-terminal part of Srs2 and showed that it was independent of the Srs2 SIM ( Figure 4B ) in accordance with the IP data. This finding (W303-1A) , uls1D (MC001), and ADH1-HA-ULS1 (MC037) strains were transformed with CUP1-SRS2 (pWJ1509) or CUP1-srs2-R1 (pAM19) plasmids and grown to logarithmic phase in selective medium followed by 4-hr incubation in the presence of 200 mM CuSO 4 to induce overexpression of SRS2 alleles. Then cells were collected for protein extraction and Western blot analysis using anti-Srs2 antibody. The srs2D mutant (MC010) was included in the analysis as a control of antibody specificity. The signal detected for Srs2 vs. total protein as determined by Ponceau-S staining was quantified for three experiments. (B) SUMOylation status of Srs2 is affected by activity of Uls1. Aliquots of protein extracts obtained in (A) were used for IP reaction with anti-Srs2 antibody. Immunoprecipitates were analyzed by immunoblotting with anti-Srs2 and anti-SUMO antibodies. Srs2-SUMO levels vs. total immunoprecipitated Srs2 from two experiments were quantified. SDs are shown and Student's t-test was used to calculate the P-value (* 0.01 , P-value # 0.05, ** 0.001 , P-value # 0.01).
is consistent with Uls1's ability to regulate Srs2 protein levels independently of Srs2's SUMOylation status ( Figure 2A ) and reports in the literature (Xie et al. 2010; Abed et al. 2011) showing that STUbLs can also bind to their substrates through SUMO-independent interactions. The fact that Uls1 can bind Srs2 in the absence of the Srs2 SIM might indicate that the Uls1-Srs2 interaction is independent from Srs2-PCNA binding and also from Srs2 SUMOylation.
We thus identified Srs2 as a possible in vivo physiological target for Uls1.
Deletion of ULS1 compromises Srs2-PCNA interaction
Previous work has demonstrated that overexpression of SRS2 has a negative effect on growth in wild type and even more so in many mutant backgrounds (Mankouri et al. 2002; León Ortiz et al. 2011 ). It has also been shown that an increased abundance of the helicase dead mutant form of Srs2 is more toxic than the wild-type protein, while overproduction of mutant forms unable to interact with PCNA, such as Srs2-R1, is not toxic in wild type and the vast majority of tested mutants (León Ortiz et al. 2011 ).
Using strains with HA-SRS2 and HA-srs2-R1 genes expressed from a methionine-repressible promoter introduced into an SRS2-endogenous locus, we examined the effect of ULS1 deletion on Srs2 overproduction toxicity. We found that when HA-SRS2 is overexpressed, the wild-type cells were much more sensitive to HU and MMS than uls1D mutant cells. Overexpression of HA-srs2-R1, however, was less toxic and conferred the similar degree of HU and MMS sensitivity in both wild type and the uls1D mutant ( Figure  5A ). Since it has been shown that SUMOylation decreases the ability of Srs2 to bind PCNA (Kolesar et al. 2012) , we propose that lower toxicity of SRS2 overexpression in the uls1D mutant results from accumulation of SUMOylated forms of Srs2 in this mutant background, as shown in Figure 2B and Figure  3B . This would compromise Srs2 binding to PCNA and reduce the toxicity of SRS2 overexpression. These data suggest a physiological function for Uls1 in regulating Srs2 binding to PCNA through modification of Srs2's SUMOylation status.
We thus assayed the influence of Uls1 on Srs2 interaction with PCNA more directly. Interestingly, we found that Uls1 itself immunoprecipitated with PCNA and this interaction (W303-1A) , uls1D (MC001), and slx5D (KK013) strains were transformed with CUP1-SRS2 (pWJ1509) and after overexpression of SRS2 (as in Figure 2 ), protein extracts were isolated and Western blot analysis with anti-Srs2 antibody was performed. The signal detected for Srs2 vs. total protein as determined by Ponceau-S staining was quantified for two experiments. (B) IP of Srs2 from extracts obtained in (A) and visualization of SUMOylated Srs2 using antiSrs2 and anti-SUMO antibody. Srs2-SUMO levels vs. total immunoprecipitated Srs2 from two experiments were quantified. (C) Uls1 and Slx5 mediate turnover of the Srs2 protein. Endogenous Srs2 level was analyzed by CHX chase. Wild type (W303-1A), uls1D (MC001), and slx5D (KK013) were synchronized in G 1 and released into YPD medium containing 0.03% MMS and 50 mg/ml CHX. At the indicated time points, cells were collected for protein extraction followed by Western blotting with the anti-Srs2 antibody. Level of G-6-PDH was used as a loading control. The srs2D mutant (MC010) was included in the analysis as a control of antibody specificity. The percentage values of relative Srs2 level vs. G-6-PDH, acquired for two experiments, are plotted. SDs are shown and Student's t-test was used to calculate the P-value (* 0.01 , P-value # 0.05).
was independent of the presence of Srs2 ( Figure 5B , galactose). Using the yeast two-hybrid system we mapped the PCNA-Uls1 interaction site to the N-terminal fragment of Uls1 and showed that Uls1 SIMs were not critical for Uls1 binding to PCNA (Pol30). We also demonstrated that the Uls1-PCNA interaction did not require PCNA SUMOylation, as the Pol30RR, lacking SUMOylation sites, and wild-type Pol30 were indistinguishable in our assay ( Figure 5C ).
Under standard growth conditions without genotoxin treatment, we could immunoprecipitate Srs2 with PCNA both in the wild-type strain and in the GALS-HA-ULS1 strain grown on galactose, but we were unable to immunoprecipitate Srs2 with PCNA in the GALS-HA-ULS1 strain grown on glucose when expression of ULS1 was blocked ( Figure 5B, glucose) . These results show that in the absence of Uls1, binding of Srs2 to PCNA is compromised. It is well documented (Le Breton et al. 2008; Kolesar et al. 2012 ) that Srs2 SUMOylation negatively affects its PCNA binding and, since we show that deletion of ULS1 leads to the accumulation of Srs2-SUMO, it follows that the Srs2-PCNA interaction would be attenuated in this mutant. Overall our results suggest that Uls1 can regulate Srs2's ability to bind PCNA by modifying Srs2's SUMOylation status.
The role of Srs2 modifications in the suppression of the sgs1D mutant phenotype by deletion of ULS1 Interestingly, lack of Srs2 SUMOylation and its binding to PCNA are not responsible for the severe growth defect observed in the sgs1D srs2D strain (Le Breton et al. 2008; Kolesar et al. 2016) . We constructed sgs1D HA-srs2-R1 and sgs1D uls1D HA-srs2-R1 mutants and found that the HA-srs2-R1 mutation diminished the extent of rescue of sgs1D mutant's HU and MMS sensitivity by deletion of ULS1, even though it had no effect on the sgs1D mutant ( Figure 6A ). This raises the possibility that not only compromising the Srs2-PCNA interaction but also accumulation of SUMOylated Srs2 may be important for the sgs1D uls1D phenotype. To test that assumption, we constructed sgs1D srs2-3KR and sgs1D uls1D srs2-3KR mutants, containing Srs2 with mutated SUMOylation sites but proficient in PCNA binding. We found that the srs2-3KR mutation also reversed the rescue of sgs1D mutant's HU and MMS sensitivity by deletion of ULS1 ( Figure  6B ), and the absence of Srs2 SUMOylation did not lead to the synthetic growth defect in the sgs1D background.
We thus propose that Srs2-SUMO is important for genome stability and may play a role in the additional salvage pathway activated in the absence of Uls1.
Rad51-dependent pathway promoted by Uls1 is responsible for the synthetic growth defect in the sgs1D mus81D double mutant It has been shown before that elimination of HR suppresses the lethality of mus81D sgs1D cells (Fabre et al. 2002) . We show that deletion of ULS1 suppresses mus81D sgs1D synthetic lethality to the same degree as deletion of RAD51. Moreover, the quadruple mutant, mus81D sgs1D rad51D GALS-HA-ULS1, has a similar phenotype ( Figure 7A ), suggesting that Uls1 assists in a Rad51-dependent pathway that becomes toxic in cells devoid of both Sgs1 and Mus81.
Attenuation of the sgs1D mutant phenotype by deletion of ULS1 requires the presence of Rad51 and Rad5 (Cal-Bąkowska et al. 2011; Kramarz et al. 2014 ), so we examined the effect of RAD5 deletion in a mus81D sgs1D background. We found that deletion of RAD5 slightly rescued the severe synthetic growth defect of the mus81D sgs1D double mutant, suggesting that some aspect of Rad5 activity may be detrimental in cells lacking Sgs1 and Mus81. Interestingly, deletion of RAD5 reversed the beneficial effect of both RAD51 as well as ULS1 deletion on the phenotype of the mus81D sgs1D mutant ( Figure 7A ). These results suggest that a functional Rad5-dependent subpathway is required for the observed rescue of synthetic lethality of the mus81D sgs1D double mutant in the rad51D and uls1D mutant backgrounds.
Since the presence of ULS1 is toxic in the mus81D sgs1D mutant background, similarly to that of RAD51, we could hypothesize that the uls1D mutation results in a partial inactivation of the Rad51-dependent pathway. To corroborate this assumption, we examined the interaction of uls1 with other mutants in two systems that are established as being indicative of attenuation of HR pathways. First, it has been shown that deletion of SRS2 rescues rad18D and rad5D mutants' slow growth as well as their UV and MMS sensitivity, in a manner dependent on the presence of Rad51, suggesting a requirement for HR (Friedl et al. 2001; Papouli et al. 2005) . If Uls1 is involved in HR, its depletion should not lead to the Figure 4 Uls1 interacts with Srs2. (A) Protein extracts prepared from srs2D ADH1-HA-ULS1 (KK032) cells overexpressing either SRS2 (from pWJ1509 plasmid) or srs2-R1 (from pAM19 plasmid) were immunoprecipitated with anti-HA antibody, followed by Western blot analysis with anti-HA and anti-Srs2 antibodies. The negative controls for IP reactions are marked as "2Ab." (B) The N-terminal part (2-878) of Uls1 (pGBKT7-Uls1_N plasmid) is responsible for interaction with C-terminal part (783-1174) of Srs2 (pLK165 plasmid) and Srs2DSIM (pLK1002 plasmid) variant as shown by yeast two-hybrid assay (in AH109 strain).
rescue of rad18D and rad5D mutants' phenotypes. In accordance with that assumption, we demonstrated that deletion of ULS1 had no effect on rad18D and rad5D mutant phenotypes and even slightly reversed the rescue observed in the rad18D srs2D and rad5D srs2D mutants ( Figure 7B ), as has been demonstrated before for Rad51 (Papouli et al. 2005) . This implies that deletion of ULS1 partially impairs the Rad51-mediated HR pathway, making the cells more reliant on the Rad18-Rad5-dependent one. Second, cells lacking a structure-selective flap endonuclease, Rad27, depend on HR for viability (Symington 1998) . We found that deletion of ULS1 in the rad27D background led to severe growth defect of double mutants, which is consistent with the role of Uls1 in the process of HR ( Figure 7C ).
We thus propose that Uls1 contributes to the pathway where intermediates generated at replication forks by Rad51 (and Rad5) are dismantled by Srs2 bound to SUMO-PCNA. Upon ULS1 deletion, accumulating Srs2-SUMO, Figure 5 The role of Uls1 in Srs2-PCNA interaction. (A) Toxic effects of SRS2 overexpression are alleviated by deletion of ULS1. Wild type (WT) (W303-1A), HA-SRS2 (CY2715), HA-SRS2 uls1D (SM001), HA-srs2-R1 (D511-4D), HA-srs2-R1 uls1D (SM002), MET25-HA-SRS2 (SM003), MET25-HA-SRS2 uls1D (SM004), MET25-HA-srs2-R1 (SM005), MET25-HA-srs2-R1 uls1D (SM006), and srs2D (MC010) were spotted onto minimal medium without methionine to induce overexpression of MET25-HA-SRS2 or MET25-HA-srs2-R1. Plates were photographed after 3 days of incubation at 30°. (B) Uls1 interacts with PCNA and promotes Srs2 binding to PCNA. Logarithmically growing cells of wild type (W303-1A), GALS-HA-ULS1 (MC038), and srs2D GALS-HA-ULS1 (KK031) were grown on either YPD medium to repress, or YPGal medium to induce, ULS1 overexpression. Aliquots of protein preparation from total cells extracts (TE) and immunoprecipitates with anti-PCNA antibody were analyzed by Western blot with anti-HA, anti-PCNA, and anti-Srs2 antibodies. The negative controls for IP reactions are marked as "2Ab." "M" stands for molecular weight marker. (C) The N-terminal part (2-878) of Uls1 (pGADT7-Uls1_N plasmid) interacts with PCNA (Pol30, #618 plasmid) and PCNA K127/164R (Pol30RR, #1040 plasmid) as shown by yeast two-hybrid assay (in AH109 strain).
unable to bind PCNA, takes part in an alternative recombination repair pathway(s) (Figure 8 ) involving other recombination factors (Kolesar et al. 2016) and possibly also Rad5.
Discussion
We report that deletion of ULS1 suppresses the severe growth defect of the mus81D sgs1D double mutant similarly to deletion of RAD51, suggesting that Uls1 may be involved in the same pathway as Rad51, leading to the accumulation of recombination intermediates that are toxic in cells devoid of both Sgs1 and Mus81. We also demonstrate that deletion of ULS1 does not lead to the rescue of the synthetic lethality of a sgs1D srs2D double mutant. Therefore we hypothesized that the Srs2-dependent pathway might play a role in the suppression of the replication stress-related defects in sgs1D and mus81D sgs1D cells by deletion of ULS1.
Consequently, we found that in the absence of Uls1, Srs2-SUMO conjugates accumulate and the protein is stabilized, as is also observed in the slx5D mutant (Urulangodi et al. 2015) . Uls1 can bind to both Srs2 and PCNA, but interestingly, we were unable to immunoprecipitate Srs2 with PCNA in the uls1D mutant, suggesting that in this mutant Srs2-PCNA interaction was attenuated. This is consistent with previous reports (Le Breton et al. 2008; Kolesar et al. 2012 ) that Srs2-SUMO is compromised in binding to PCNA. This result suggests that Uls1, by limiting the pool of SUMOylated Srs2, may promote the Srs2-PCNA interaction.
It has been shown before that the ability of Srs2 to bind PCNA is responsible for the toxicity of Srs2 overproduction in most mutant backgrounds, and that overexpression of srs2-R1 (unable to bind PCNA and not SUMOylated) is not detrimental (León Ortiz et al. 2011) . Consistently with our biochemical findings, we demonstrate that deletion of ULS1 reduces the toxicity of SRS2 overexpression in wild type. This result supports our conjecture that the form of Srs2 abundant in the absence of Uls1 is indeed defective in PCNA binding. We thus propose Srs2 to be a physiological target for Uls1.
Taken together, our data imply that during the replication stress response, Uls1 influences Srs2-and Sgs1-dependent pathways. In S. cerevisiae cells grown under unperturbed conditions, replication forks can encounter various obstacles, leading to fork stalling, collapse, or even DSB formation. In response to such mild replication stress, Rad51-and Rad5-dependent, error-free postreplication pathways like SDSA and the PCNA polyubiquitination-dependent template switch are activated (Branzei et al. 2008; Burkovics et al. 2013; Miura et al. 2013) . Additionally, PCNA-SUMO mediates the Figure 6 Srs2 involvement in the suppression of sgs1D mutant phenotype by deletion of ULS1. (A) The presence of srs2-R1 decreased synthetic rescue observed in sgs1D uls1D. sgs1D HA-SRS2 (SM007), sgs1D uls1D HA-SRS2 (SM008), sgs1D HA-srs2-R1 (SM009), and sgs1D uls1D HA-srs2-R1 (SM010) were spotted onto YPD plates in the presence or absence genotoxic agents. (B) Synthetic rescue phenotype visible in sgs1D uls1D depends on the presence of SUMOylated form of Srs2. srs2-3KR (SS149-15D) was introduced into sgs1D (MC012) and sgs1D uls1D (MC013), and growth of resulting mutants sgs1D srs2-3KR (KK033) and sgs1D uls1D srs2-3KR (KK034) on plates with HU and MMS was examined. Figure 7 Uls1 acts on Rad51-dependent pathway. (A) The effect of depletion of Uls1, Rad5, and Rad51 on suppression of synthetic lethality of mus81D sgs1D double mutant. Wild type (WT) (W303-1A), mus81D sgs1D rad51D (KK030), mus81D sgs1D rad5D (KK035), mus81D sgs1D GALS-HA-ULS1 (KK029), mus81D sgs1D rad51D rad5D (KK036), mus81D sgs1D rad51D GALS-HA-ULS1 (KK037), mus81D sgs1D rad5D GALS-HA-ULS1 (KK038), and mus81D sgs1D rad51D rad5D GALS-HA-ULS1 (KK039) were spotted onto YPD plates in the presence or absence of genotoxins. (B) Comparison of suppression of rad18D and rad5D DNA-damage sensitivity in cells devoid of Srs2 and Uls1. Indicated strains rad5D (KK040), rad5D uls1D (KK041), rad5D srs2D (KK042), rad5D srs2D uls1D (KK043), rad18D (MC035), rad18D uls1D (MC036), rad18D srs2D (KK044), and rad18D srs2D uls1D (KK045) were spotted onto YPD medium containing DNA damaging agents. (C) uls1D exhibits synthetic growth defect with rad27D. Heterozygous diploid strains for both mutations were sporulated and tetrads were dissected to examine growth of indicated haploid strains rad27D (KK046) and rad27D uls1D (KK047). recruitment of the Srs2 helicase to the replication fork (Papouli et al. 2005; Pfander et al. 2005) . In this way, recombination at the replication fork is downregulated. Genetic data from S. cerevisiae suggest that Sgs1 is involved in promoting SDSA (Mitchel et al. 2013) , although its exact activity is uncertain. Sgs1 has also been implicated in a dissolution of Rad5-mediated template switch intermediates (Branzei et al. 2008 ) and reversion of regressed replication forks (Lo et al. 2006) . We demonstrate that Uls1 promotes Srs2 binding to PCNA, presumably by decreasing the amount of Srs2-SUMO at replication forks. So we propose a model in which Uls1 acts by channeling Rad51-and Rad5-generated intermediates into the PCNA-Srs2-dependent pathway (Figure 8 ). We infer that this is the source of Uls1 toxicity in sgs1D as well as in the mus81D sgs1D mutant.
In the uls1D mutant, the Srs2-SUMO accumulates and is unable to bind PCNA. We have shown that both HA-srs2-R1 (not SUMOylated and unable to bind PCNA) and srs2-3KR (not SUMOylated but able to bind PCNA) reverse the rescue of MMS and HU sensitivity conferred by ULS1 deletion in the sgs1D mutant. This suggests that not only decreased PCNA binding but also the activity of SUMOylated Srs2 contribute to the suppression of the phenotypes of sgs1D and possibly also of mus81D sgs1D mutants. These results support a conclusion, also suggested in previous reports (Saponaro et al. 2010; Kolesar et al. 2016) , that SUMOylated Srs2 is active in PCNA-independent recombination repair pathways, and not only targeted for degradation. We propose that in uls1D mutants Srs2 activity is redirected toward these alternative pathways (Figure 8 ).
Rad5 has also been shown to mediate postreplication repair by replication fork reversal (Minca and Kowalski 2010) and D-loop invasion (Burkovics et al. 2014) independently of Rad51 and perhaps also of PCNA. Interestingly, we demonstrate that the Rad5-dependent pathway is required for the rescue of the mus81D sgs1D mutant's severe growth defect by deletion of RAD51 or ULS1. Rad5, together with Srs2-SUMO, is also required for the rescue of the sgs1D mutant's HU and MMS sensitivity by deletion of ULS1 (Kramarz et al. 2014 ), so we propose that Rad5 could participate in the alternative pathway activated in the uls1D mutant when SUMOylated Srs2 accumulates.
There is increasing evidence that during unperturbed replication and at very low levels of DNA damage, Rad18-dependent DDT is the pathway of choice, with the error-free Rad5-(and Rad51-) dependent template switch operating during S phase, and error-prone synthesis active mainly on ssDNA gaps in G 2 (Hishida et al. 2010; Huang et al. 2013; Lehner and Jinks-Robertson 2014) . We postulate that this error-free pathway is stimulated by Uls1. It is known, however, that SUMO conjugation of PCNA is not triggered exclusively in S phase, but also during severe DNA damage (Hoege et al. 2002) , so under such conditions a switch to another pathway of DDT most probably occurs. One candidate pathway has recently been proposed (Urulangodi et al. 2015) where Elg1, Esc2, and the Slx5-Slx8 complex collaborate to limit the Srs2 antirecombinase activity at the sites of replication-associated damage. Interestingly, Uls1 and Slx5 have been shown to interact physically with Elg1, but the phenotypes of elg1D uls1D and elg1D slx5D double mutants are different and the slx5D mutant is sensitive to MMS, while uls1D is not (Cal-Bąkowska et al. 2011; Parnas et al. 2011) . Interaction with Slx5 has been proposed to be important for Uls1 activity, but the relationship between the two proteins was antagonistic (Tan et al. 2013) . This suggests that Uls1 and Slx5 are not redundant, and have unique functions in the cell. We could speculate that the former may operate during low and the latter at high levels of replication stress. This would be consistent with the lack of DNA-damage sensitivity in uls1D as opposed to the high sensitivity of slx5D, and the synthetic sickness observed in a double mutant devoid of both Uls1 and Slx5 (Kramarz et al. 2014) .
The evidence is mounting that Uls1 may play an important role in DNA metabolism by targeting different SUMO-modified proteins. It would thus be very interesting in the future to determine the identity of other Uls1 partners and elucidate the nature of the interplay between Uls1-and Slx5-regulated pathways. search Center (Krajowy Naukowy Ośrodek Wiodący) for years 2014-2018." 
